A Mechanism for Hyporeninemic Hypoaldosteronism in Chronic Renal Disease
Overview
Affiliations
Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD).
Ali M, Parveen S, Williams V, Dons R, Uwaifo G J Clin Transl Endocrinol. 2024; 36:100341.
PMID: 38616864 PMC: 11015524. DOI: 10.1016/j.jcte.2024.100341.
Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy.
Roscioni S, de Zeeuw D, Bakker S, Lambers Heerspink H Nat Rev Nephrol. 2012; 8(12):691-9.
PMID: 23070570 DOI: 10.1038/nrneph.2012.217.
Hypoaldosteronism without hyperkalemia.
Weidmann P, Gluck Z, Keusch G, REUBI F, de Chatel R, Cottier C Klin Wochenschr. 1980; 58(4):185-94.
PMID: 6991789 DOI: 10.1007/BF01476777.
[The renin-angiotensin system in diabetic patients].
Mann J, Ritz E Klin Wochenschr. 1988; 66(18):883-91.
PMID: 3054274 DOI: 10.1007/BF01728950.
Heterogeneous changes of serum potassium levels in NIDDM patients on oral glucose load.
Bae H, Kim H Korean J Intern Med. 1992; 7(1):39-47.
PMID: 1477029 PMC: 4532097. DOI: 10.3904/kjim.1992.7.1.39.